Orion Corp. B Aktie
70,15 €
Deine Einschätzung
Orion Corp. B Aktie
Was spricht für und gegen Orion Corp. B in den nächsten Jahren?
Pro
Kontra
Rendite von Orion Corp. B im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Orion Corp. B | 0,00 % | 4,47 % | 1,74 % | 11,97 % | 9,70 % | 77,19 % | 87,77 % |
| Sihuan Pharmaceutical Holdings Group Ltd. | -0,51 % | -4,81 % | -23,85 % | -19,51 % | -24,43 % | 20,00 % | -71,71 % |
| Swedish Orphan Biovitrum Ab | -1,40 % | -0,79 % | -0,64 % | 42,97 % | 30,40 % | 109,08 % | 156,63 % |
| Almirall S.A. | 0,18 % | 2,39 % | -7,32 % | 0,00 % | -13,91 % | 28,12 % | -22,75 % |
Kommentare
News
Is Redwire Stock a Buy Ahead of the SpaceX IPO?
SpaceX is set to make its public market debut in June and is likely to be the largest initial public offering (IPO) on record. As the company gears up to go public, investors are beginning to pay
Orion Office REIT Q1 Earnings Call Highlights
Orion Office REIT (NYSE:ONL) said its first-quarter results reflected continued progress on leasing, asset sales and balance-sheet management, while its board and management continue to evaluate
Orion Q1 Earnings Call Highlights
Orion (NYSE:OEC) raised its full-year earnings outlook after reporting first-quarter adjusted EBITDA that exceeded internal




